奈妥吡坦 Netupitant
【化学名】奈妥吡坦 Netupitant
【原研】罗氏
【上市时间】2014年10月10日
【用途】用于治疗恶心，呕吐
【剂型/规格】胶囊 300mg;EQ 0.5mg BASE ；冻干 EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL ；静脉注射液 EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML)
奈妥吡坦Netupitant
一、产品概述
Netupitant奈妥匹坦，由罗氏首先研发，用于治疗恶心、呕吐；后由Helsinn研发其复方制剂奈妥吡坦/盐酸帕洛诺司琼。2014年10月10日，奈妥吡坦/盐酸帕洛诺司琼获得FDA批准，由赫尔辛医疗股份公司销售，商品名为Akynzeo
二、主要产品
Description | Structural Formula | CAS No. | Category |
Netupitant |
| 290297-26-6 | API |
2-(3,5-bis(trifluoromethyl) phenyl)-2-methylpropanoic acid |
| 289686-70-0 | intermediates |
3-Pyridinecarboxamide, 4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)- |
| 342417-01-0 | intermediates |
3-Pyridinamine,N-methyl-4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)- |
| 290297-25-5 | intermediates |
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.